Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Juhyun Kim, Ronghua Wang, Karen A. Veverka & James T. Dalton. (2013) Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in rats. Xenobiotica 43:11, pages 993-1009.
Read now
Read now
Sarah J. Roffey, R. Scott Obach, Jenny I. Gedge & Dennis A. Smith. (2007) What is the Objective of the Mass Balance Study? A Retrospective Analysis of Data in Animal and Human Excretion Studies Employing Radiolabeled Drugs. Drug Metabolism Reviews 39:1, pages 17-43.
Read now
Read now
Yves Fradet. (2004) Bicalutamide (Casodex®) in the treatment of prostate cancer. Expert Review of Anticancer Therapy 4:1, pages 37-48.
Read now
Read now
Paul F Schellhammer. (2002) An evaluation of bicalutamide in the treatment of prostate cancer. Expert Opinion on Pharmacotherapy 3:9, pages 1313-1328.
Read now
Read now
D. McKILLOP*C. J. BUTTERS, S. J. HILL, P. J. SIMONS, T. L. EDWARDS & S. E. DOUGHTY. (1998) Enzyme-inducing effects of bicalutamide in mouse, rat and dog. Xenobiotica 28:5, pages 465-478.
Read now
Read now
A. Mukherjee, L. Kirkovsky, X. T. Yao, R. C. Yates, D. D. Miller & J. T. Dalton. (1996) Enantioselective binding of Casodex to the androgen receptor. Xenobiotica 26:2, pages 117-122.
Read now
Read now
D. McKillop, P. J. Simons, I. D. Cockshott, S. J. Hill, J. R. Harding, K. J. Cooper & D. C. Jones. (1995) Enantioselective metabolism and pharmacokinetics of Casodex in the male rat. Xenobiotica 25:6, pages 623-633.
Read now
Read now
G. W. Boyle, D. McKillop, P. J. Phillips, J. R. Harding, R. Pickford & A. D. McCormick. (1993) Metabolism of Casodex in laboratory animals. Xenobiotica 23:7, pages 781-798.
Read now
Read now
Articles from other publishers (39)
Qi-Dong Xia, Si-Han Zhang, Na Zeng, Yu-Chao Lu, Bao-Long Qin & Shao-Gang Wang. (2023) Novel androgen receptor inhibitors for metastatic hormone-sensitive prostate cancer: Current application and future perspectives. Biomedicine & Pharmacotherapy 168, pages 115806.
Crossref
Crossref
Mercedes Zurro, Sergio Torres‐Oya & Estíbaliz Merino. (2023) Visible‐Light‐Mediated Synthesis of Bicalutamide by Regioselective Hydroxysulfonylation of Acrylamides. European Journal of Organic Chemistry.
Crossref
Crossref
Tessa C.A. van Tongeren, Thomas E. Moxon, Matthew P. Dent, Hequn Li, Paul L. Carmichael & Ivonne M.C.M. Rietjens. (2021) Next generation risk assessment of human exposure to anti-androgens using newly defined comparator compound values. Toxicology in Vitro 73, pages 105132.
Crossref
Crossref
Arwed Cleve & Duy Nguyen. 2018. Successful Drug Discovery. Successful Drug Discovery
95
110
.
Peter R. Bradshaw, Ian D. Wilson, Rachel Upcott Gill, Philip J. Butler, Clive Dilworth & Toby J. Athersuch. (2018) Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human In Vitro Systems. Scientific Reports 8:1.
Crossref
Crossref
Changcheng Guo, Shuyuan Yeh, Yuanjie Niu, Gonghui Li, Junhua Zheng, Lei Li & Chawnshang Chang. (2017) Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer. Cancer Letters 397, pages 133-143.
Crossref
Crossref
Dante Rojas, Gaud Dervilly-Pinel, Nora Cesbron, Mylène Penot, Alexandre Sydor, Stéphanie Prévost & Bruno Le Bizec. (2017) Selective androgen receptor modulators: comparative excretion study of bicalutamide in bovine urine and faeces. Drug Testing and Analysis 9:7, pages 1017-1025.
Crossref
Crossref
Payal Rana, Yvonne Will, Sashi Nadanaciva & Lyn H. Jones. (2016) Development of a cell viability assay to assess drug metabolite structure–toxicity relationships. Bioorganic & Medicinal Chemistry Letters 26:16, pages 4003-4006.
Crossref
Crossref
Kyoung-Ah Kim, Yu-Jung Cha, Hae-Mi Lee, Hyun-Jin Joo & Ji-Young Park. (2015) Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans. Clinica Chimica Acta 438, pages 7-11.
Crossref
Crossref
Lin Xu. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
4
.
Laurent Grosse, Anne-Sophie Campeau, Sarah Caron, Frédéric-Alexandre Morin, Kim Meunier, Jocelyn Trottier, Patrick Caron, Mélanie Verreault & Olivier Barbier. (2013) Enantiomer Selective Glucuronidation of the Non-Steroidal Pure Anti-Androgen Bicalutamide by Human Liver and Kidney: Role of the Human UDP-Glucuronosyltransferase (UGT)1A9 Enzyme. Basic & Clinical Pharmacology & Toxicology 113:2, pages 92-102.
Crossref
Crossref
N. T. Ramarao, S. Vidyadhara, R. L. C. Sasidhar, B. Deepti & R. Surendra Yadav. (2013) Development and Validation of LC-MS/MS Method for the Quantification of Chiral Separated R-Bicalutamide in Human Plasma. American Journal of Analytical Chemistry 04:02, pages 63-76.
Crossref
Crossref
Satoshi Yamamoto, Hiromi Kobayashi, Tomohiro Kaku, Katsuji Aikawa, Takahito Hara, Masuo Yamaoka, Naoyuki Kanzaki, Atsushi Hasuoka, Atsuo Baba & Mitsuhiro Ito. (2013) Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry 21:1, pages 70-83.
Crossref
Crossref
Kuldeep Sharma, Gopal V. Pawar, Sanjeev Giri, Sriram Rajagopal & Ramesh Mullangi. (2012) Development and validation of a highly sensitive LC‐MS/MS‐ESI method for the determination of bicalutamide in mouse plasma: application to a pharmacokinetic study. Biomedical Chromatography 26:12, pages 1589-1595.
Crossref
Crossref
Satoshi Yamamoto, Naoki Tomita, Yuri Suzuki, Tomohiko Suzaki, Tomohiro Kaku, Takahito Hara, Masuo Yamaoka, Naoyuki Kanzaki, Atsushi Hasuoka, Atsuo Baba & Mitsuhiro Ito. (2012) Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry 20:7, pages 2338-2352.
Crossref
Crossref
Z. ZHAO, F. XUE, L. ZHANG, K. ZHANG, C. FEI, W. ZHENG, X. WANG, M. WANG, Z. ZHAO & X. MENG. (2010)
The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability
in vitro
. Journal of Veterinary Pharmacology and Therapeutics 33:2, pages 147-153.
Crossref
Crossref
James T. Dalton & Wenqing Gao. 2010. Nuclear Receptors. Nuclear Receptors
143
182
.
SeungHwan Lee, Yong-Ju Chung, Bo-Hyung Kim, Jun-Hwa Shim, Seo-Hyun Yoon, Sang-Goo Shin, In-Jin Jang & Kyung-Sang Yu. (2009) Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: An open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers. Clinical Therapeutics 31:12, pages 3000-3008.
Crossref
Crossref
Michael L. Mohler, Casey E. Bohl, Amanda Jones, Christopher C. Coss, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. (2009) Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit. Journal of Medicinal Chemistry 52:12, pages 3597-3617.
Crossref
Crossref
Geert J. C. M. Kolvenbag & Barrington J.A. Furr. 2009. Hormone Therapy in Breast and Prostate Cancer. Hormone Therapy in Breast and Prostate Cancer
347
368
.
Michael D. Axelson & David E. Gerber. 2009. Pharmaceutical Perspectives of Cancer Therapeutics. Pharmaceutical Perspectives of Cancer Therapeutics
321
363
.
R. Nageswara Rao, A. Narasa Raju & R. Narsimha. (2008) Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study. Journal of Pharmaceutical and Biomedical Analysis 46:3, pages 505-519.
Crossref
Crossref
Aya Fujino, Masayoshi Asano, Hitomi Yamaguchi, Naoki Shirasaka, Akiko Sakoda, Masaya Ikunaka, Rika Obata, Shigeru Nishiyama & Takeshi Sugai. (2007) Bacillus subtilis epoxide hydrolase-catalyzed preparation of enantiopure 2-methylpropane-1,2,3-triol monobenzyl ether and its application to expeditious synthesis of (R)-bicalutamide. Tetrahedron Letters 48:6, pages 979-983.
Crossref
Crossref
Stefan Horkovics-Kovats & Pavol Zlatoš. (2006) Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization. Mathematical Biosciences 203:1, pages 19-36.
Crossref
Crossref
R. Nageswara Rao, A. Narasa Raju & D. Nagaraju. (2006) An improved and validated LC method for resolution of bicalutamide enantiomers using amylose tris-(3,5-dimethylphenylcarbamate) as a chiral stationary phase. Journal of Pharmaceutical and Biomedical Analysis 42:3, pages 347-353.
Crossref
Crossref
Wenqing Gao, Juhyun Kim & James T. Dalton. (2006) Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands. Pharmaceutical Research 23:8, pages 1641-1658.
Crossref
Crossref
Di Wu, Zengru Wu, Jun Yang, Vipin A. Nair, Duane D. Miller & James T. Dalton. (2006) PHARMACOKINETICS AND METABOLISM OF A SELECTIVE ANDROGEN RECEPTOR MODULATOR IN RATS: IMPLICATION OF MOLECULAR PROPERTIES AND INTENSIVE METABOLIC PROFILE TO INVESTIGATE IDEAL PHARMACOKINETIC CHARACTERISTICS OF A PROPANAMIDE IN PRECLINICAL STUDY. Drug Metabolism and Disposition 34:3, pages 483-494.
Crossref
Crossref
Wenqing Gao, Zengru Wu, Casey E. Bohl, Jun Yang, Duane D. Miller & James T. Dalton. (2006) CHARACTERIZATION OF THE IN VITRO METABOLISM OF SELECTIVE ANDROGEN RECEPTOR MODULATOR USING HUMAN, RAT, AND DOG LIVER ENZYME PREPARATIONS. Drug Metabolism and Disposition 34:2, pages 243-253.
Crossref
Crossref
Wenqing Gao, Casey E. Bohl & James T. Dalton. (2005) Chemistry and Structural Biology of Androgen Receptor. Chemical Reviews 105:9, pages 3352-3370.
Crossref
Crossref
Hiroshi Miyamoto, Edward M. Messing & Chawnshang Chang. (2004) Androgen deprivation therapy for prostate cancer: Current status and future prospects. The Prostate 61:4, pages 332-353.
Crossref
Crossref
Ian D Cockshott. (2004) Bicalutamide. Clinical Pharmacokinetics 43:13, pages 855-878.
Crossref
Crossref
Kenneth D James & Nnochiri N Ekwuribe. (2002) Syntheses of enantiomerically pure (R)- and (S)-bicalutamide. Tetrahedron 58:29, pages 5905-5908.
Crossref
Crossref
Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. GoppeltStrübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Messinger, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst & D. Youssef. 1999. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
127
188
.
Robert L. Rosati, Paul Da Silva Jardine, Kimberly O. Cameron, David D. Thompson, Hua Zhu Ke, Steven M. Toler, Thomas A. Brown, Lydia C. Pan, Charles F. Ebbinghaus, Anthony R. Reinhold, Nancy C. Elliott, Bradley N. Newhouse, Christina M. Tjoa, Paul M. Sweetnam, Mark J. Cole, Mark W. Arriola, Jeffrey W. Gauthier, D. Todd Crawford, David F. Nickerson, Christine M. Pirie, Hong Qi, Hollis A. Simmons & George T. Tkalcevic. (1998) Discovery and Preclinical Pharmacology of a Novel, Potent, Nonsteroidal Estrogen Receptor Agonist/Antagonist, CP-336156, a Diaryltetrahydronaphthalene. Journal of Medicinal Chemistry 41:16, pages 2928-2931.
Crossref
Crossref
David G. McLeod. (1997) Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer. The Oncologist 2:1, pages 18-27.
Crossref
Crossref
Ernest J Dole & Mark T Holdsworth. (2016) Nilutamide: An Antiandrogen for the Treatment of Prostate Cancer. Annals of Pharmacotherapy 31:1, pages 65-75.
Crossref
Crossref
Louis Denis & C. Mahler. (1996) Pharmacodynamics and pharmacokinetics of bicalutamide: defining an active dosing regimen. Urology 47:1, pages 26-28.
Crossref
Crossref
Michel Eichelbaum & Annette S. Gross. 1996. Advances in Drug Research Volume 28. Advances in Drug Research Volume 28
1
64
.
I. D. COCKSHOTT, E. A. SOTANIEMI, K. J. COOPER & D. C. JONES. (2012) The pharmacokinetics of Casodex enantiomers in subjects with impaired liver function. British Journal of Clinical Pharmacology 36:4, pages 339-343.
Crossref
Crossref